Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Em — RYAN CIRZ (REVAGENIX, INC.)
To support the advanced development of candidate therapeutics for biodefense pathogens or emerging infectious diseases. The supported research and development activities will progress the therapeutic
| Project title | Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Em |
|---|---|
| Project number | 75N93022C00061-P00002-9999-1 |
| PI name | RYAN CIRZ |
| Institution | REVAGENIX, INC. |
| Funding mechanism | N01 |
| Agency | NIAID |
| Award amount | $11.27M |
| Fiscal year | 2024 |
| Project start | 2022-09-22T00:00:00 |
| Project end | 2025-08-31T00:00:00 |
| Abstract | To support the advanced development of candidate therapeutics for biodefense pathogens or emerging infectious diseases. The supported research and development activities will progress the therapeutic |
| Key terms | <Advanced Development><Bacteria resistance><Bacteria resistant><Bacterial Drug Resistance><Bacterial |
$799/mo
Try GrantRadar →